BeOne Medicines Ltd. Sponsored ADR (ONC) surged 3.97% after the company reported robust third-quarter 2026 results and significantly raised full-year guidance, driven by strong revenue gains and ...
BeOne Medicines Ltd. Sponsored ADR (ONC) surged 5.15% amid clear technical momentum, as strength across all key moving averages and a rebound toward intraday highs fueled the advance. The move is ...
BeOne Medicines Ltd. Sponsored ADR (ONC) fell 5.77% on heavy intraday selling pressure as technical signals show both short- and medium-term momentum remain bearish. The weakness is supported by ...
BeOne Medicines Ltd. Sponsored ADR (ONC) surged 3.68% on strong technical momentum, with buyers dominating action throughout the session. The up move is supported by the stock trading well above ...
BeOne Medicines Ltd. Sponsored ADR (ONC) surged 5.46% after reporting strong second-quarter 2026 results driven by robust revenue and a significant jump in earnings per share. The move is ...
BeOne Medicines (ONC) stock is trading at $285.55, down 1.53% on the day. The stock remains above its near-term moving averages but has not reclaimed its longer-term ...